Berry and oat shakes tested as Heart-Health boosters
NCT ID NCT03620266
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether daily shakes made from bilberries and oats can lower LDL cholesterol and improve exercise capacity in people who have had a heart attack or have type 2 diabetes. 900 participants will drink either a bilberry shake, an oat shake, a combination shake, or a placebo shake twice a day for three months. The goal is to see if these simple dietary additions can provide extra heart protection on top of standard medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bilberry and oat shakes
What this could lead to
If it works, this could offer a simple, safe dietary strategy to help manage cholesterol and inflammation in people with heart disease or diabetes.
What could go wrong
This is a mid-sized study, not a large final-stage trial. The effects may be small or not clinically meaningful, and the shakes are taken alongside standard medications, not replacing them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiology Clinic, Västmanlands sjukhus
Västerås, 721 89, Sweden
-
Department of Cardiology, Skånes universitetssjukhus
Lund, 221 00, Sweden
-
Department of Cardiology, Örebro University Hospital
Örebro, 701 85, Sweden
-
Falu lasarett
Falun, Sweden
-
Karlstad general hospital
Karlstad, Sweden
-
Odense University Hospital
Odense, Denmark
-
Sahlgrenska Universitetssjukhuset
Gothenburg, Sweden
-
Steno Diabetes center
Aarhus, Denmark